![]() Lioma also runs CapeBio Technologies, a spin-off company from the Council of Scientific and Industrial Research. ![]() Lioma’s brainchild will have a turnaround time of a maximum of 48 hours and have on-site diagnosis.īut, Lioma says the health sphere is heavily regulated and while they await the go-ahead to perform clinical trials, the first pilot is likely to be performed by the end of 2019. It can take up to three weeks and during this period the disease could spread. She presented the concept to IBM, which helped the fledgling company develop a software platform.ĭeep Medical Therapeutics plans to reduce the time people spend waiting for their results to come back from the laboratory. ![]() We can use artificial intelligence technology to pick up drug resistance unique genetic strains,” Lioma explains. “Drug resistance diseases mutate and people can develop drug resistance if they don’t take drugs correctly. “Imagine a strand of hair and splitting that strand.”Ĭoming back to South Africa, Lioma founded Deep Medical Therapeutics, which leverages the power of artificial intelligence (AI) in the medical field. She describes nanotechnology as the study of very small particles on a Nano scale. I’ve seen how universities and business can work together,” Lioma says. I got an offer to do a PhD there but I thought to come home and impact South Africa. “I learned quite a lot I really saw how powerful science can be to change the world. She counts as inspiration her exposure to the commercial aspect of science while studying towards her MPhil degree in microtechnology and nanotechnology at Cambridge University in the United Kingdom. At just 29, Dineo Lioma is a scientist and astute businesswomen, having founded three companies in the scientific sphere.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |